| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Sanders Corazon (Corsee) D. | Director | C/O ULTRAGENYX PHARMACEUTICAL INC., 60 LEVERONI COURT, NOVATO | /s/ Karah Parschauer, attorney-in-fact | 23 Jun 2025 | 0001796536 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | RARE | Common Stock | Sale | $89,923 | -2,405 | -14% | $37.39 | 15,344 | 20 Jun 2025 | Direct |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).